Buprenorphine Withdrawal: Understanding Symptoms, Duration, and How To Stay Safe
Frequently Asked Questions About Buprenorphine Withdrawal
How long will my buprenorphine withdrawal last?
Withdrawal from buprenorphine can last anywhere from one to four weeks depending on the dose and how long you were using the medication. If discontinuation is abrupt, physical symptoms will reach their peak sometime between days 4-7. Over the course of weeks 2-4, most individuals experience a gradual decline in physical withdrawal symptoms, possibly with continued psychological distress (depression, fatigue etc.) continuing into months 3-4. Some individuals who taper off of buprenorphine continue to experience post-acute withdrawal syndrome (PAWS) symptoms which include prolonged low-mood, disruptions in sleep patterns and persistent cravings for opioids.
What will my Suboxone withdrawal timeline look like?
Suboxone contains buprenorphine, and its withdrawal timeline is similar to that of buprenorphine. With abrupt discontinuation, symptoms generally start appearing 24-72 hours after your last dose. Peak symptoms usually occur within a week. Symptoms typically subside over days 14-28.
Should I quit taking buprenorphine cold turkey?
Cold-turkey quitting buprenorphine is ill-advised. Abruptly ceasing buprenorphine can lead to severe withdrawal symptoms and greatly increases the likelihood of relapse. The safest method to discontinue buprenorphine is a medically supervised taper with regular dose reductions determined by a qualified healthcare provider.
What is the safest way to taper off buprenorphine?
The recommendation to taper off of buprenorphine is to reduce the dose by 10 to 25 percent every 1-2 weeks under close supervision of a licensed healthcare provider. As you get closer to discontinuing the medication, the taper should occur more gradually. A slow taper gives your body adequate time to readjust to each successive reduction in medication. Based upon how you are responding to each interval of tapering, adjustments can be made to the pace of the taper. Emotional support should also be provided during this process, along with ongoing monitoring for potential relapse.
Is buprenorphine withdrawal more severe than heroin or oxycodone withdrawal?
Generally, buprenorphine withdrawal is less intense than withdrawal from heroin or oxycodone. Due to its long half-life and partial agonist activity at opioid receptors in the central nervous system, buprenorphine withdrawal is generally less intense than withdrawal from shorter-acting opioids such as heroin or oxycodone.
What are the most common buprenorphine withdrawal symptoms?
Some of the most common physical symptoms of buprenorphine withdrawal include nausea, vomiting, diarrhea, stomach cramps, headache, fatigue, fever, muscle pain, chills, runny nose, sneezing, and sweating. In addition to physical symptoms, many individuals experience significant psychological symptoms such as anxiety, depression, mood swings, strong cravings, difficulty concentrating, loss of motivation or pleasure, memory loss, and confusion.
When will my buprenorphine withdrawal symptoms begin?
As mentioned above, withdrawal from buprenorphine at lower doses (less than 4mg/day) typically begins within four to six hours of the last dose, whereas withdrawal at higher doses (more than 8mg/day) usually doesn’t begin until twenty-four hours or more after your last dose. Again, this timeline may vary for different individuals.
[1] National Center for Biotechnology Information. (2024). Opioid receptors. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK546642/
[2] MedlinePlus. (n.d.). Buprenorphine sublingual and buccal. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a605002.html#side-effects
[3] Soyka, M., Trader, A., Klotsche, J., & Backmund, M. (2010). Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation. Alcohol and Alcoholism, 45(3), 241–245. https://academic.oup.com/alcalc/article-abstract/45/3/241/208730?redirectedFrom=fulltext
[4] MedlinePlus. (n.d.). Buprenorphine sublingual and buccal. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a605002.html
[5] Gowing, L., Ali, R., White, J. M., & Mbewe, D. (2017). Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(2). https://pmc.ncbi.nlm.nih.gov/articles/PMC4447545/
[6] Substance Abuse and Mental Health Services Administration. (n.d.). Medications for substance use disorders. U.S. Department of Health and Human Services. https://www.samhsa.gov/medications-substance-use-disorders
[7] Sigmon, S. C. (2015). The untapped potential of office-based buprenorphine treatment. JAMA Psychiatry, 72(4), 395–396. https://pmc.ncbi.nlm.nih.gov/articles/PMC2818765/
[8] Substance Abuse and Mental Health Services Administration. (2021). Buprenorphine quick start guide. U.S. Department of Health and Human Services. https://library.samhsa.gov/sites/default/files/buprenorphine-quick-start-guide.pdf